The roadmap to geographic atrophy treatment: A journey of trials and promise

Omer Trivizki; Anat Loewenstein; Dinah Zur

doi:10.1111/aos.15801

The roadmap to geographic atrophy treatment: A journey of trials and promise

Omer Trivizki^*
, Anat Loewenstein
, Dinah Zur

^*Corresponding author for this work

Ophthalmology

University of Miami

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

This review covers advancements in geographic atrophy (GA) research. It discusses genetic contributions to AMD, explores treatment strategies, including complement inhibition, and highlights recent FDA approvals, safety concerns and promising future directions.

Original language	English
Pages (from-to)	891-895
Number of pages	5
Journal	Acta Ophthalmologica
Volume	101
Issue number	8
DOIs	https://doi.org/10.1111/aos.15801
State	Published - Dec 2023

Access to Document

10.1111/aos.15801

Cite this

@article{10cf6bf45b784d50b1b2db763903bf94,

title = "The roadmap to geographic atrophy treatment: A journey of trials and promise",

abstract = "This review covers advancements in geographic atrophy (GA) research. It discusses genetic contributions to AMD, explores treatment strategies, including complement inhibition, and highlights recent FDA approvals, safety concerns and promising future directions.",

author = "Omer Trivizki and Anat Loewenstein and Dinah Zur",

note = "Publisher Copyright: {\textcopyright} 2023 The Authors. Acta Ophthalmologica published by John Wiley \& Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.",

year = "2023",

month = dec,

doi = "10.1111/aos.15801",

language = "אנגלית",

volume = "101",

pages = "891--895",

journal = "Acta Ophthalmologica",

issn = "1755-375X",

publisher = "John Wiley and Sons Inc.",

number = "8",

}

TY - JOUR

T1 - The roadmap to geographic atrophy treatment

T2 - A journey of trials and promise

AU - Trivizki, Omer

AU - Loewenstein, Anat

AU - Zur, Dinah

PY - 2023/12

Y1 - 2023/12

N2 - This review covers advancements in geographic atrophy (GA) research. It discusses genetic contributions to AMD, explores treatment strategies, including complement inhibition, and highlights recent FDA approvals, safety concerns and promising future directions.

AB - This review covers advancements in geographic atrophy (GA) research. It discusses genetic contributions to AMD, explores treatment strategies, including complement inhibition, and highlights recent FDA approvals, safety concerns and promising future directions.

UR - https://www.scopus.com/pages/publications/85175958025

U2 - 10.1111/aos.15801

DO - 10.1111/aos.15801

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

C2 - 37933605

AN - SCOPUS:85175958025

SN - 1755-375X

VL - 101

SP - 891

EP - 895

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

IS - 8

ER -

The roadmap to geographic atrophy treatment: A journey of trials and promise

Abstract

Access to Document

Other files and links

Fingerprint

Cite this